These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3563845)

  • 1. Accurate prognostic value of morphovolumetric analysis of advanced carcinoma of the stomach.
    Haraguchi M; Okamura T; Sugimachi K
    Surg Gynecol Obstet; 1987 Apr; 164(4):335-9. PubMed ID: 3563845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of serosal invasion in carcinoma of the stomach.
    Haraguchi M; Watanabe A; Kakeji Y; Tsujitani S; Baba H; Maehara Y; Sugimachi K
    Surg Gynecol Obstet; 1991 Jan; 172(1):29-32. PubMed ID: 1985338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infiltration of S-100 protein positive dendritic cells and peritoneal recurrence in advanced gastric cancer.
    Tsujitani S; Kakeji Y; Watanabe A; Kohnoe S; Maehara Y; Sugimaghi K
    Int Surg; 1992; 77(4):238-41. PubMed ID: 1478802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological study of diffuse carcinoma of stomach (author's transl)].
    Shimoda T
    Hokkaido Igaku Zasshi; 1978 Nov; 52(6):305-25. PubMed ID: 204562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of intratumoral natural killer cells in gastric carcinoma.
    Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Che X; Iwashige H; Aridome K; Hokita S; Aikou T
    Cancer; 2000 Feb; 88(3):577-83. PubMed ID: 10649250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tumor infiltration pattern into the surrounding tissue on prognosis of the subserosal gastric cancer (pT2b).
    Song KY; Hur H; Jung CK; Jung ES; Kim SN; Jeon HM; Park CH
    Eur J Surg Oncol; 2010 Jun; 36(6):563-7. PubMed ID: 20462730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS; Wu TL; Tsao KC; Sun CF
    Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma of the gastric cardia.
    Hölscher AH; Bollschweiler E; Siewert JR
    Ann Chir Gynaecol; 1995; 84(2):185-92. PubMed ID: 7574379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
    Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
    Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of gastric carcinoma invading the muscularis propria.
    Otsuji E; Kuriu Y; Ichikawa D; Okamoto K; Hagiwara A; Yamagishi H
    J Surg Oncol; 2005 Nov; 92(2):104-8. PubMed ID: 16231368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
    Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
    Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
    Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
    Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.
    Yasuda K; Shiraishi N; Inomata M; Shiroshita H; Izumi K; Kitano S
    Hepatogastroenterology; 2007; 54(79):2028-31. PubMed ID: 18251153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The metastatic patterns of gastric cancer from its histopathological characteristics in the primary lesion--particularly in relation to peritoneal dissemination and liver metastases].
    Takahashi Y; Mai M; Ogino T; Ueda H; Kitamura T; Sawaguchi K; Ueno M; Minami S
    Gan No Rinsho; 1985 Nov; 31(14):1792-6. PubMed ID: 4087385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between expression of RB protein and prognosis of gastric cancer].
    Ogawa M; Maeda K; Chung YS; Onoda N; Kato Y; Nakata B; Sowa M
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():148-50. PubMed ID: 8678558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic studies on gastric cancer with concomitant liver metastases.
    Fujisaki S; Tomita R; Nezu T; Kimizuka K; Park E; Fukuzawa M
    Hepatogastroenterology; 2001; 48(39):892-4. PubMed ID: 11462950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.
    Lo SS; Wu CW; Chi CW; Li AF; Chen JH; Lui WY
    Hepatogastroenterology; 2005; 52(66):1902-4. PubMed ID: 16334803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of gastric cancer with concomitant liver metastases.
    Kwok CM; Wu CW; Lo SS; Shen KH; Hsieh MC; Lui WY
    Hepatogastroenterology; 2004; 51(59):1527-30. PubMed ID: 15362793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.